[go: up one dir, main page]

EP1581635A4 - SILENCING MEDIA GENES BY SIRNA - Google Patents

SILENCING MEDIA GENES BY SIRNA

Info

Publication number
EP1581635A4
EP1581635A4 EP03814141A EP03814141A EP1581635A4 EP 1581635 A4 EP1581635 A4 EP 1581635A4 EP 03814141 A EP03814141 A EP 03814141A EP 03814141 A EP03814141 A EP 03814141A EP 1581635 A4 EP1581635 A4 EP 1581635A4
Authority
EP
European Patent Office
Prior art keywords
sirna
genes
silencing
media
silencing media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03814141A
Other languages
German (de)
French (fr)
Other versions
EP1581635A2 (en
Inventor
Henry Paulson
Victor Miller
Cynthia Gouvion
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/430,351 external-priority patent/US20040023390A1/en
Priority claimed from PCT/US2003/016887 external-priority patent/WO2004013280A2/en
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Publication of EP1581635A2 publication Critical patent/EP1581635A2/en
Publication of EP1581635A4 publication Critical patent/EP1581635A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01031—Beta-glucuronidase (3.2.1.31)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/30—Production chemically synthesised
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to small interfering RNA molecules (sIRNA) targeted against an allele of interest, and methods of using these sIRNA molecules.
EP03814141A 2002-12-17 2003-12-16 SILENCING MEDIA GENES BY SIRNA Withdrawn EP1581635A4 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US430351 1982-09-29
US32208602A 2002-12-17 2002-12-17
US322086 2002-12-17
US10/430,351 US20040023390A1 (en) 2002-08-05 2003-05-05 SiRNA-mediated gene silencing with viral vectors
PCT/US2003/016887 WO2004013280A2 (en) 2002-08-05 2003-05-26 ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
WOPCT/US03/16887 2003-05-26
PCT/US2003/040292 WO2004058940A2 (en) 2002-08-05 2003-12-16 Sirna-mediated gene silencing

Publications (2)

Publication Number Publication Date
EP1581635A2 EP1581635A2 (en) 2005-10-05
EP1581635A4 true EP1581635A4 (en) 2007-10-17

Family

ID=32685878

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03814141A Withdrawn EP1581635A4 (en) 2002-12-17 2003-12-16 SILENCING MEDIA GENES BY SIRNA

Country Status (2)

Country Link
EP (1) EP1581635A4 (en)
AU (1) AU2003301030A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013355A1 (en) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation Sirna-mediated gene silencing with viral vectors
WO2004013280A2 (en) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
WO2004047872A2 (en) * 2002-11-26 2004-06-10 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004013355A1 (en) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation Sirna-mediated gene silencing with viral vectors
WO2004013280A2 (en) * 2002-08-05 2004-02-12 University Of Iowa Research Foundation ALLELE-SPECIFIC siRNA-MEDIATED GENE SILENCING
WO2004047872A2 (en) * 2002-11-26 2004-06-10 Medtronic, Inc. Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna)

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BRUMMELKAMP T R ET AL: "STABLE SUPPRESSION OF TUMORIGENICITY BY VIRUS-MEDIATED RNA INTERFERENCE", CANCER CELL, XX, US, vol. 2, no. 3, September 2002 (2002-09-01), pages 243 - 247, XP009006464, ISSN: 1535-6108 *
DING H ET AL: "Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis", AGING CELL, BLACKWELL PUBLISHING,, GB, vol. 2, 2003, pages 209 - 217, XP002389534, ISSN: 1474-9718 *
DONZE O ET AL: "RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 30, no. 10, 15 May 2002 (2002-05-15), pages e46 - 1, XP002279045, ISSN: 0305-1048 *
MILLER V M ET AL: "Allele-specific silencing of dominant disease genes", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 100, no. 12, 10 June 2003 (2003-06-10), pages 7195 - 7200, XP002278730, ISSN: 0027-8424 *
MILLER V M ET AL: "Targeting Alzheimer's disease genes with RNA interference: An efficient strategy for silencing mutant alleles", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 32, no. 2, 2004, pages 661 - 668, XP002315762, ISSN: 0305-1048 *
SCHWARZ D.S. ET AL: "Asymmetry in the assembly of the RNAi enzyme complex", CELL, vol. 115, 17 October 2003 (2003-10-17), pages 199 - 208, XP002521543, DOI: 10.1016/S0092-8674(03)00759-1 *

Also Published As

Publication number Publication date
AU2003301030A1 (en) 2004-07-22
EP1581635A2 (en) 2005-10-05
AU2003301030A8 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
WO2004058940A3 (en) Sirna-mediated gene silencing
WO2006083800A3 (en) Nucleic acid silencing of huntington's disease gene
WO2004045543A3 (en) Functional and hyperfunctional sirna
WO2006006948A3 (en) METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
WO2006031267A3 (en) Rna interference suppression of neurodegenerative diseases and methods of use thereof
WO2006085987A3 (en) Rna interference in respiratory epitheial cells
WO2004061081A3 (en) Sirna compounds and methods for the downregulation of gene expression
WO2004065613A3 (en) Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
NO20082783L (en) Inducible expression systems
DE60207601D1 (en) METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOBBELSTRÄNGIGEN RNAS
WO2008150897A3 (en) Reduction of off-target rna interference toxicity
ATE439440T1 (en) SIRNA-MEDIATED GENE SILENCING OF ALPHA-SYNUKLEIN
EP1442143A4 (en) INHIBITION OF RNA INTERFERENCE-INDUCED BCL2 GENE EXPRESSION USING SMALL INTERFERING NUCLEIC ACIDS (SINA)
WO2003064621A3 (en) HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
WO2007135685A3 (en) Compositions for silencing the expression of gibberellin 2-oxidase and uses thereof
DK1399590T3 (en) Happier mapping
WO2004087947A8 (en) Aptamer selection method
WO2006013072A3 (en) Method for isolation of transcription termination sequences
WO2005042705A3 (en) Short interfering rna and micro-rna compounds and methods of designing, making and using the same
WO2007014077A3 (en) Rnai modulation of the rho-a gene and uses thereof
EP1581635A4 (en) SILENCING MEDIA GENES BY SIRNA
WO2006045591A3 (en) Method and constructs for delivering double stranded rna to pest organisms
EP2772541A3 (en) Targeting opposite strand replication intermediates of hepatitis C virus by RNAi
ATE428783T1 (en) EXPRESSION SYSTEM FOR SIRNA
DE602004022282D1 (en) METHOD FOR THE AMPLIFICATION OF NUCLEIC ACID SEQUENCES BY MEANS OF TRIED LIGATION

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050715

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07H 21/04 20060101ALI20060530BHEP

Ipc: C07H 21/02 20060101ALI20060530BHEP

Ipc: A01N 47/40 20060101ALI20060530BHEP

Ipc: C12N 15/63 20060101ALI20060530BHEP

Ipc: C12N 15/00 20060101ALI20060530BHEP

Ipc: C12P 19/34 20060101ALI20060530BHEP

Ipc: C12Q 1/68 20060101AFI20060530BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20070914

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 48/00 20060101ALI20070910BHEP

Ipc: A61K 38/00 20060101ALI20070910BHEP

Ipc: C07H 21/04 20060101ALI20070910BHEP

Ipc: C12N 15/11 20060101AFI20070910BHEP

17Q First examination report despatched

Effective date: 20080310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090906